针对性TNBC治疗的siRNA药物输送策略的进展
Md Abdus Subhan1,2, Vladimir P Torchilin3,4
1Division of Nephrology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA.
Bioengineering (Basel, Switzerland)
|August 29, 2024
概括
三阴性乳腺癌 (TNBC) 是具有攻击性的,缺乏向治疗选择. 基于纳米材料的siRNA传递提供了一种有希望的方法来降低关键基因的调节,改善TNBC患者的预后和降低死亡率.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有不良预后的侵袭性亚型.
- 由于TNBC缺乏特定的分子标 (ER,PR,HER2),这使得向治疗复杂化.
- 目前的化疗等治疗方法面临药物耐药性和复发的挑战.
研究的目的:
- 审查基于纳米材料和纳米生物材料的siRNA输送平台在TNBC治疗方面的进展.
- 探索针对TNBC中关键基因,蛋白质和转录因子 (TF) 的向治疗方法.
- 突出基于siRNA的疗法在改善TNBC预后和降低死亡率方面的潜力.
主要方法:
- 对TNBC的siRNA传递系统的最新科学文献的审查.
- 讨论利用纳米材料在TNBC中进行基因沉默的有针对性的方法.
- 对生物工程siRNA药物用于同时降低基因调节的分析.
主要成果:
- 基于纳米材料的siRNA传递平台显示了针对性TNBC治疗的前景.
- 在TNBC中准高调基因,蛋白质和TFs可以破坏与预后不佳相关的途径.
- 通过生物工程siRNA同时静止基因,可以显著减少TNBC的进展.
结论:
- 基于siRNA的疗法,特别是通过纳米材料提供的疗法,代表了TNBC治疗的前沿.
- 有针对性的基因沉默为克服当前TNBC疗法的局限性提供了一种策略.
- 纳米医学的进步对于开发针对激进乳腺癌的有效和少毒治疗方法至关重要.
相关概念视频
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Small interfering RNAs (siRNA)
3.5K
3.5K


